- Previous Close
1.4900 - Open
1.6600 - Bid 1.6600 x --
- Ask 1.7200 x --
- Day's Range
1.6600 - 1.6600 - 52 Week Range
1.4300 - 4.4600 - Volume
0 - Avg. Volume
340 - Market Cap (intraday)
1.092B - Beta (5Y Monthly) 0.38
- PE Ratio (TTM)
13.83 - EPS (TTM)
0.1200 - Earnings Date Mar 27, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Jun 30, 2023
- 1y Target Est
--
Hygeia Healthcare Holdings Co., Limited offers oncology healthcare services in the People's Republic of China. The company owns and operates private for-profit hospitals that offers oncology healthcare services, such as radiotherapy, chemotherapy, surgery, and targeted therapy, as well as cancer diagnosis, treatment, and rehabilitation. It also provides radiotherapy services to third-party hospitals, including radiotherapy center consulting services, licensing of radiotherapy equipment for use in the radiotherapy centers, and maintenance and technical support services for radiotherapy equipment. In addition, the company provides management services to private not-for-profit hospitals, as well as supply chain services; sells pharmaceutical, medical consumables, and medical equipment to third parties; and produces proprietary SRT equipment. The company was founded in 2009 and is headquartered in Shanghai, the People's Republic of China.
www.hygeia-group.com.cn8,169
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 50I.SG
View MorePerformance Overview: 50I.SG
Trailing total returns as of 4/10/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 50I.SG
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 50I.SG
View MoreValuation Measures
Market Cap
936.57M
Enterprise Value
1.20B
Trailing P/E
12.18
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.64
Price/Book (mrq)
1.08
Enterprise Value/Revenue
2.16
Enterprise Value/EBITDA
11.68
Financial Highlights
Profitability and Income Statement
Profit Margin
13.46%
Return on Assets (ttm)
4.72%
Return on Equity (ttm)
9.26%
Revenue (ttm)
4.45B
Net Income Avi to Common (ttm)
598.26M
Diluted EPS (ttm)
0.1200
Balance Sheet and Cash Flow
Total Cash (mrq)
651.59M
Total Debt/Equity (mrq)
41.82%
Levered Free Cash Flow (ttm)
--